Medical Countermeasures: Long-Term Funding Could Spur More Development Work
Chimerix CEO tells Congress allocating Project Bioshield a multi-year funding stream would provide more long-term certainty for countermeasure sponsors.
You may also be interested in...
US Pandemic and All Hazards Preparedness Act appears on track for on-time reauthorization – but there may still be debate over whether and how to dedicate funding specifically for pandemic flu preparedness and stockpiling.
Commissioner Gottlieb proposes new authorities that could require manufacturers of certain drugs to establish risk mitigation plans to avert potential drug shortages.
Only the first publicly disclosed sale of a priority review voucher was lower than what Jazz Pharmaceuticals paid Spark Therapeutics for its coupon.